AR038524A1 - Derivados de fenalenona, procedimiento para su preparacion y utilizacion de los mismos - Google Patents

Derivados de fenalenona, procedimiento para su preparacion y utilizacion de los mismos

Info

Publication number
AR038524A1
AR038524A1 ARP030100503A ARP030100503A AR038524A1 AR 038524 A1 AR038524 A1 AR 038524A1 AR P030100503 A ARP030100503 A AR P030100503A AR P030100503 A ARP030100503 A AR P030100503A AR 038524 A1 AR038524 A1 AR 038524A1
Authority
AR
Argentina
Prior art keywords
formula
alkenyl
alkyl
branched
linear
Prior art date
Application number
ARP030100503A
Other languages
English (en)
Spanish (es)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of AR038524A1 publication Critical patent/AR038524A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92Naphthofurans; Hydrogenated naphthofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/04Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/80Penicillium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Furan Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
ARP030100503A 2002-02-18 2003-02-14 Derivados de fenalenona, procedimiento para su preparacion y utilizacion de los mismos AR038524A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10206849A DE10206849A1 (de) 2002-02-18 2002-02-18 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
AR038524A1 true AR038524A1 (es) 2005-01-19

Family

ID=27674733

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100503A AR038524A1 (es) 2002-02-18 2003-02-14 Derivados de fenalenona, procedimiento para su preparacion y utilizacion de los mismos

Country Status (10)

Country Link
EP (1) EP1478731A1 (enExample)
JP (1) JP2005517710A (enExample)
AR (1) AR038524A1 (enExample)
AU (1) AU2003210205B2 (enExample)
BR (1) BR0307733A (enExample)
CA (1) CA2476618A1 (enExample)
DE (1) DE10206849A1 (enExample)
MX (1) MXPA04007918A (enExample)
PE (1) PE20030904A1 (enExample)
WO (1) WO2003068946A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2415768B8 (en) 2009-03-30 2015-06-24 Nippon Suisan Kaisha, Ltd. Tricyclic condensed heterocyclic compound, method for producing same, and use thereof
WO2011009899A2 (en) * 2009-07-22 2011-01-27 Instituto Biomar, S.A. Phenalenones as antitumoral agents
FR2987622B1 (fr) * 2012-03-02 2016-01-15 Centre Nat Rech Scient Composes oxo-phenalenes, leur preparation et utilisation dans les domaines des materiaux et therapeutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2812510B2 (ja) * 1989-10-06 1998-10-22 日清製油株式会社 アトロベネチンの用途
EP1151295A4 (en) * 1999-02-01 2005-03-30 Cytovia Inc TECHNIQUES FOR IDENTIFICATION OF THERAPEUTICALLY EFFECTIVE ANTINEOPLASTIC AGENTS WITH INTACT CELL MEMBRANE CULTURE CELLS AND PRODUCTS THEREOF

Also Published As

Publication number Publication date
AU2003210205B2 (en) 2007-06-14
BR0307733A (pt) 2005-01-25
WO2003068946A1 (de) 2003-08-21
DE10206849A1 (de) 2005-07-28
PE20030904A1 (es) 2003-11-18
MXPA04007918A (es) 2004-11-26
EP1478731A1 (de) 2004-11-24
JP2005517710A (ja) 2005-06-16
CA2476618A1 (en) 2003-08-21
AU2003210205A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
BR0113861A (pt) Derivados de ácidos 3-(heteroaril acetamido)-2-oxo-azetidina-1-sulfÈnicos como agentes antibacterianos
CY1110019T1 (el) Συνδυασμενη θεραπεια με υποκατεστημενες οξαζολιδινονες
CY1106801T1 (el) Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα
UY26782A1 (es) Derivados del benzotiazol
NI200700107A (es) (bifenil) ácidos carboxílicos y sus derivados
AR032436A1 (es) Oxazolidinonas substituidas, procedimiento para su preparacion, medicamentos, el uso de las mismas para la fabricacion de medicamentos, y el metodo para impedir la coagulacion sanguinea in vitro
AR026173A1 (es) Inhibidores de neuraminidasas.
ES2213732T3 (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
ES2017837A6 (es) Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
DK0462812T3 (da) Pyranderivater som inhibitorer af 5-lipoxygenase
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
EA200800303A1 (ru) Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами
DE602005013793D1 (de) Thiazolderivate mit vap-1-hemmender wirkung
CO2025007341A2 (es) Inhibidor del inflamosoma nlrp3 y uso de este
ES2098947T3 (es) Derivados de beta,beta-dimetil-4-piperidinoetanamina como inhibidores de la biosintesis del colesterol.
UY27338A1 (es) Nuevos derivados de ácido sulfónico
DE60311869D1 (de) Kristalline cefdinirsalze
UY26951A1 (es) Derivados de ácido propiónico
AU9576901A (en) Preparation for the relief of disease
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
HRP20030907B1 (hr) Farmaceutska kompozicija na bazi makrolida za lokalnu upotrebu u oftalmologiji
AR081514A1 (es) El compuesto 4-[etil(dimetil)amonio]butanoato, el metodo para la preparacion del mismo y el uso en el tratamiento de la enfermedad cardiovascular
AR038524A1 (es) Derivados de fenalenona, procedimiento para su preparacion y utilizacion de los mismos
AR077429A1 (es) Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos
SE0004101D0 (sv) New use

Legal Events

Date Code Title Description
FA Abandonment or withdrawal